Association between Glucagon-like Peptide-1 Receptor Agonist Use and Nonarteritic Anterior Ischemic Optic Neuropathy with Optic Disc Drusen
Authors:
- 16 June 2026
- journal article
- Published by Elsevier in Ophthalmology
- Vol. 133 (10) , 1282-1284
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Semaglutide and the Risk of Nonarteritic Ischemic Optic NeuropathyOphthalmology, 2026
- Semaglutide or Tirzepatide and Optic Nerve and Visual Pathway Disorders in Type 2 DiabetesJAMA Network Open, 2025
- Semaglutide and Nonarteritic Anterior Ischemic Optic NeuropathyJAMA Ophthalmology, 2025
- The Effect of Semaglutide and GLP-1 RAs on Risk of Nonarteritic Anterior Ischemic Optic NeuropathyAmerican Journal of Ophthalmology, 2025
- Association between Semaglutide and Nonarteritic Anterior Ischemic Optic NeuropathyOphthalmology, 2024
- Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed SemaglutideJAMA Ophthalmology, 2024
- Optic Nerve Head Anatomy and Vascular Risk Factors in Patients With Optic Disc Drusen Associated Anterior Ischemic Optic NeuropathyAmerican Journal of Ophthalmology, 2022